RAEB-1

Known as: RAEB-I 
A myelodysplastic syndrome defined by 5-9% blasts in the bone marrow, and <5% blasts in the blood. Approximately 25% of cases progress to an acute… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
A cohort of MDS patients was examined for mutations affecting 4 splice genes (SF3B1, SRSF2, ZRSR2, and U2AF35) and evaluated in… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Prognostic factors for response and survival in higher-risk myelodysplastic syndrome patients treated with azacitidine (AZA… (More)
  • table 2
  • table 1
  • table 3
  • table 4
  • figure 1
Is this relevant?
2011
2011
MicroRNAs (miRNAs) are small non-coding RNAs functioning as regulators of hematopoiesis. Their differential expression patterns… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2010
2010
BACKGROUND Recently, we demonstrated immunological and clinical responses to a RHAMM-R3 peptide vaccine in patients with acute… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2010
2010
Our previous studies showed that single nucleotide polymorphism arrays (SNP-As), applied as a karyotyping platform, complement… (More)
  • figure 1
  • table 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
We evaluated the impact of World Health Organization (WHO) classification and WHO classification-based Prognostic Scoring System… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
The World Health Organization (WHO) classification contributes to refined classification and prognostication of myelodysplastic… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PURPOSE The aim of this study was to evaluate the prognostic value of the WHO proposal, to assess the role of the main prognostic… (More)
Is this relevant?
2003
2003
Antithymocyte globulin (ATG) has recently been popularized as an effective treatment in myelodysplastic syndrome (MDS). We… (More)
  • table 1
Is this relevant?
2001
2001
In 1999 a working group of the World Health Organization (WHO) published a revised classification for myelodysplastic syndromes… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?